Review paper
Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?
Abstract
Purpose of review Migraine is the second leading cause of years lived with disability after back pain. Poor tolerability, contraindications, drug–drug interactions and efficacy limited to a subpopulation make new approaches necessary for the acute and preventive treatment of migraine. The study of the calcitonin-gene-related peptide (CGRP) pathway over the last decades is a good example of translational medicine leading to directed therapies for...
Paper Details
Title
Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?
Published Date
Jun 1, 2020
Journal
Volume
33
Issue
3
Pages
309 - 315
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History